Creating a Global Company

24 29 29 FY11 TUC FY12 India Business - Sales ramp-up 10 year CAGR -16% Sales in Rs. Billion, One-time impact of change in 97 Impact of distribution Ranbaxy Acquisition 30 37 103 Therapeutic Revenue Break-up** Others Opthalmology 2% 4% Urology 3% Gynaecology, 4% Vitamins/ Minerals / Nutrients, 5% Cardiology 17% 80 77 73 71 Respiratory 5% 67 Dermatology, 6% Market Share 8.2% Neuro-Psychiatry 16% FY16 FY17 Pain / Analgesics 7% Diabetology 8% Gastroenterology 12% Anti-Infectives 11% ** As per AIOCD AWACS - Dec'21 26 SUN PHARMA

View entire presentation